Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Matthew J. Hoptman, PhD reports financial support was provided by American Foundation for Suicide Prevention. Matthew J. Hoptman, PhD reports a relationship with Kessler Research Foundation that includes consulting or advisory and serves on the Editorial board of Brain Sciences and is an Associate Editor for Frontiers of Psychiatry - Schizophrenia Section. Katherine A. Collins, PhD, consults for Cronos Clinical Consulting, Inc. In the past five years, Dr. Iosifescu has received consulting fees from Alkermes, Allergan, Angelini, Axsome, Biogen, Centers for Psychiatric Excellence, Clexio, Global Medical Education, Boehringer Ingelheim, Neuroma, Jazz, Lundbeck, Otsuka, Precision Neuroscience, Relmada, Sage, and Sunovion, and has received research support (through his academic institutions) from Alkermes, Astra Zeneca, Brainsway, LiteCure, Neosync, Otsuka, Roche, and Shire. All other authors declare no competing interests.